Arem Pacific Corporation (ARPC)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | 36.71 Thousand USD | -68.98% |
| 2022 | 118.37 Thousand USD | -12.99% |
| 2021 | 136.04 Thousand USD | 73.37% |
| 2020 | 78.47 Thousand USD | 498.46% |
| 2019 | 13.11 Thousand USD | 0.0% |
| 2016 | 46.35 Thousand USD | 173.34% |
| 2015 | -100.1 Thousand USD | -285.66% |
| 2014 | -73.62 Thousand USD | -190.12% |
| 2013 | 26.66 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | 33.55 Thousand USD | -7.44% |
| 2024 Q3 | 8375.00 USD | -76.6% |
| 2024 Q2 | 36.56 Thousand USD | 6.64% |
| 2023 Q1 | 53.09 Thousand USD | 5161.94% |
| 2023 FY | - USD | -68.98% |
| 2023 Q4 | 36.25 Thousand USD | 136.76% |
| 2023 Q3 | -98.63 Thousand USD | -314.41% |
| 2023 Q2 | 46 Thousand USD | -13.36% |
| 2022 Q4 | 1009.00 USD | -97.08% |
| 2022 FY | - USD | -12.99% |
| 2022 Q2 | 59.26 Thousand USD | 151.21% |
| 2022 Q1 | 23.59 Thousand USD | 0.0% |
| 2022 Q3 | 34.51 Thousand USD | -41.77% |
| 2021 FY | - USD | 73.37% |
| 2020 FY | - USD | 498.46% |
| 2019 FY | - USD | 0.0% |
| 2017 Q1 | 17.75 Thousand USD | 153.37% |
| 2016 Q2 | 5705.00 USD | -73.46% |
| 2016 Q4 | 7009.00 USD | -73.49% |
| 2016 Q1 | 21.49 Thousand USD | 161.55% |
| 2016 Q3 | 26.44 Thousand USD | 363.52% |
| 2016 FY | - USD | 173.34% |
| 2015 Q2 | -43.47 Thousand USD | -1619.74% |
| 2015 FY | - USD | -285.66% |
| 2015 Q4 | -34.92 Thousand USD | -144.52% |
| 2015 Q3 | -14.28 Thousand USD | 67.15% |
| 2015 Q1 | -2528.00 USD | 96.65% |
| 2014 Q4 | -75.44 Thousand USD | 0.0% |
| 2014 FY | - USD | -190.12% |
| 2013 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| The Amacore Group, Inc. | -10.98 Million USD | 100.334% |
| Assisted 4 Living, Inc. | -112.91 Thousand USD | 132.517% |
| BioCorRx Inc. | -2.68 Million USD | 101.368% |
| Bionik Laboratories Corp. | -4.77 Million USD | 100.769% |
| Banyan Corp. | 583.94 Thousand USD | 93.713% |
| Clearday, Inc. | -7.53 Million USD | 100.487% |
| Dental Patient Care America, Inc. | 12.87 Thousand USD | -185.209% |
| Quantum Medical Transport, Inc. | - USD | -Infinity% |
| Empower Clinics Inc. | -1.08 Million USD | 103.374% |
| First Choice Healthcare Solutions, Inc. | -2.2 Million USD | 101.661% |
| Selectis Health, Inc. | -7.29 Million USD | 100.503% |
| Ethema Health Corporation | 2.07 Million USD | 98.228% |
| HealthLynked Corp. | -2.75 Million USD | 101.335% |
| HQDA Elderly Life Network Corp. | - USD | -Infinity% |
| Healthcare Solutions Management Group, Inc. | -2.65 Million USD | 101.383% |
| JRSIS Health Care Corporation | 28.84 Thousand USD | -27.279% |
| Comjoyful International Company | 167.89 Thousand USD | 78.132% |
| Medical Facilities Corporation | 77.94 Million USD | 99.953% |
| MedSmart Group Inc. | 47.8 Thousand USD | 23.205% |
| North America Frac Sand, Inc. | -623.33 Thousand USD | 105.89% |
| Nova Leap Health Corp. | 994.46 Thousand USD | 96.308% |
| Nexteligent Holdings, Inc. | -201.73 Thousand USD | 118.2% |
| PAO Group, Inc. | 292.96 Thousand USD | 87.468% |
| Primemd Inc. | 3.42 Million USD | 98.929% |
| Raffles Medical Group Ltd | 100.7 Million USD | 99.964% |
| Ryman Healthcare Limited | -54.51 Million USD | 100.067% |
| Stem Cell Authority, Ltd. | -4233.00 USD | 967.352% |
| SETO Holdings, Inc. | - USD | -Infinity% |
| Optima Medical Innovations Corp. | -2.89 Million USD | 101.269% |
| Mycotopia Therapies, Inc. | -555.5 Thousand USD | 106.609% |
| U.S. NeuroSurgical Holdings, Inc. | -49 Thousand USD | 174.929% |
| Veltex Corporation | -938.45 Thousand USD | 103.912% |
| World Financial Holding Group | -28.43 Thousand USD | 229.142% |
| Xcelerate Inc. | -2.53 Million USD | 101.446% |